Thomas Saglimbeni
Family · New York, NYNPI 1396142618
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $35,482 of the $48,441 with a category attached, or 73.2%. Viiv Healthcare Company accounts for 83.6% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2022 at $25,307 and has fallen 99.2% since, to $200 in 2024. Among family clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 347 payments — averaging $139.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$41K
- Gilead$5K
- AbbVie$431
- Johnson & Johnson$412
- Lilly USA, LLC$258
- Merck$231
- plus $2K from 27 others
What the payments were for
- Consulting fees$5431%
- Speaking & faculty fees$35,48273%
- Travel & lodging$3,9748%
- Food & beverage$8,23817%
- Education$2050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 130 | $40,509 |
| Gilead | 71 | $4,604 |
| AbbVie | 17 | $431 |
| Johnson & Johnson(2 entities) | 16 | $412 |
| Lilly USA, LLC | 15 | $258 |
| Merck | 10 | $231 |
| Theratechnologies Inc. | 6 | $218 |
| Lundbeck LLC | 10 | $204 |
| Novo Nordisk | 8 | $164 |
| EMD Serono, Inc. | 10 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $147 |
| Harmony Biosciences LLC | 4 | $131 |
| Janssen Products, LP | 1 | $100 |
| Idorsia Pharmaceuticals US Inc | 5 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $87 |
| Kowa Pharmaceuticals America, Inc. | 5 | $82 |
| Antares Pharma, Inc. | 4 | $77 |
| Supernus Pharmaceuticals, Inc. | 3 | $73 |
| Boehringer Ingelheim | 3 | $71 |
| Alkermes, Inc. | 2 | $42 |
| GSK | 2 | $41 |
| Phadia US Inc. | 2 | $37 |
| Corium, LLC | 1 | $34 |
| Astellas Pharma US Inc | 2 | $33 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $28 |
| Amgen | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Napo Pharmaceuticals Inc | 1 | $22 |
| Bausch Health US, LLC | 1 | $21 |
| Halozyme Inc | 1 | $21 |
| AstraZeneca | 1 | $21 |
| Acerus Pharmaceuticals Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$48,441 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Other family in New York
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Mary Sullivan-WhalenNew York$137K
- Leslie WoronaNew York$77K
- Kathryn JohnsonNew York$48K
- Derek PinedaNew York$38K
- Rebecca SchoriNew York$32K
- Evangelia NezisNew York$22K
- Colette NelsonNew York$21K
- Margaret CuomoNew York$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.